Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer

Advancements in minimal residual disease detection in myeloma

New classification for identifying HR myeloma based on cytogenetic abnormalities

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Revolutionising myeloma treatment through immune profiling

Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Advancements in paediatric Acute lymphoblastic leukemia management

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Choosing 1st line TKI Wisely in patients with CML

TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC

CAR-T - Choosing Wisely